The hepatitis diagnosis market is expected to grow in upcoming years due to factors such as increase in incidence of hepatitis disease around the world, demand for diagnostic system and techniques for determining the virus.
Hepatitis diagnosis is performed for determining the genotype of hepatitis which is causing the disease. The diagnosis of hepatitis helps in determining the best treatment available for the patient. Different types of hepatitis virusesshow similar symptoms; so it is important to diagnose the disease in order to identify the virus. Hepatitis is caused due to inflammation in liver. Hepatitis is differentiated into different types of virus such as Hepatitis A, B and C. Diagnosis of hepatitis disease is done through blood testing. Hepatitis can also be diagnosed by testing the genetic material or proteins in the body, which are part of the virus.
COVID-19 scenario analysis:
At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis. Considering these factors, COVID -19 is expected to have significant impact on hepatitis diagnosis market.
Top Impacting factors:
- Factors such as rise in incidence of hepatitis disease around the world and need for a diagnostic system for detection of virus type is expected to boost the growth of the hepatitis diagnosis market over the forecast period.
- Increase in awareness about the benefits of testing of hepatitis disease for proper detection, prevention and course of treatment is expected to drive the growth for hepatitis diagnosis market in upcoming years.
- Rise in the campaigns conducted by the government and non-government organizations for increasing the awareness and knowledge about hepatitis has positively impacted the hepatitis diagnosis market growth.
- Increase in demand for automation in diagnosis of hepatitis is expected to fuel the market growth.
- However, factors such as high cost associated with NAT (Nucleic Acid Amplification Technique), and lack of any compulsory directive issued by the regulatory authorities in developing countries is expected to hinder the growth of hepatitis diagnosis market up to some extent over the forecast period.
New Product Launch / News:
- In March 2020, FDA cleared the Alinity m system for use with Abbott’s HCV (hepatitis C) assay. Abbott said it is working with hospitals and health systems in the U.S. to install this new instrument, which will help keep up with the growing demand for testing.
- In 2020, Oscar Medicare, Delhi, India-based in-vitro diagnostic kits manufacturing company, offered a range of Rapid tests, ELISA Kits, Serology Kits, Biochemistry reagent kits and others. HBsAg ELISA is intended to be used for the detection of hepatitis B surface antigen (HBsAg) in human serum or plasma.
- In November 2017, World Hepatitis Summit was held in Sao Paulo, Brazil from November1-3, 2017, for discussing the advancements in the hepatitis market.
Key benefits of the report:
- This study presents the analytical depiction of the hepatitis diagnosis market along with the current trends and future estimations to determine the investments.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of thehepatitis diagnosis market share.
- The current market is quantitatively analyzed to highlight the Hepatitis DiagnosisMarketgrowth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed hepatitis diagnosis market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in thehepatitis diagnosismarketReport:
- Who are the leading market players active inthe hepatitis diagnosis market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
- What segments and region will drive the market growth & why?
Key Market Segments
- By Disease Type
- Hepatitis B
- Hepatitis C
- Other Disease type
- By Test
- Blood Tests
- Immunoassays
- Nucleic Acid Tests
- Liver Function Tests
- Imaging Tests
- Liver Biopsy
- By Technology
- ELISA
- Rapid Diagnostics test
- PCR
- INAAT
- Other Technologies
- By End User
- Hospitals and Diagnostics Labs
- Blood Banks
- Other end users
- By Region
- North America
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- Bio-Rad
- Abbott Laboratories
- Ortho Clinical Diagnostics
- Danaher Corporation
- DiaSorin
- Grifols
- QIAGEN
- Roche
- Siemens Corporation
- bioMérieux